[
  {
    "id": "leukoplakia_36115_1750166912.txt-1",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#definitiongeneral255307",
    "clean_content": "Definition / general\n\n* Hyperkeratotic (white) plaque / patch of mucosa exhibiting clonality and representing precursor lesion to [squamous cell carcinoma](https://www.pathologyoutlines.com/topic/oralcavityscc.html)\n  + Approximately 40% of leukoplakias exhibit keratinizing dysplasia ([Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:713](25457889))+ Remaining exhibit hyperkeratosis / parakeratosis characterized genomically by *KMT2C, TP53, TIAM1* or other mutations ([Oral Dis 2019;25:1707](31295753))* Term leukoplakia / leukoplakic also used descriptively in clinical setting to denote any white lesion without a readily apparent diagnosis\n    + Such use may skew understanding of leukoplakia biology / behavior due to preponderance of frictional / reactive keratoses in oral cavity, which are not always recognizable clinically but have no malignant potential ([Head Neck Pathol 2019;13:423](30887394))* Defined by WHO as a white plaque of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer ([J Oral Pathol Med 2007;36:575](17944749))* Leukoplakia may occur throughout the upper aerodigestive tract"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-2",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#essentialfeatures255308",
    "clean_content": "Essential features\n\n* Hyperkeratotic (white) plaque / patch of mucosa exhibiting clonality and representing precursor lesion to squamous cell carcinoma* Approximately 40% of leukoplakias exhibit keratinizing dysplasia; the remainder are characterized by hyperkeratosis alone* Annual malignant transformation rate is 3% and most strongly predicted by presence of dysplasia on biopsy; increasing duration, increasing size and nonhomogenous appearance also associated with malignant transformation* Leukoplakia exhibiting hyperkeratosis that is not frictional / reactive exhibits a malignant transformation rate of approximately 5%, similar to that of mild epithelial dysplasia* Histologic appearance of leukoplakia indistinguishable from proliferative (verrucous) leukoplakia and requires clinical correlation* Surgical excision reduces risk of malignant transformation approximately 3 times"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-3",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#terminology255309",
    "clean_content": "Terminology\n\n* Leukoplasia, erythroleukoplakia, erythroplakia"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-4",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#icdcoding255310",
    "clean_content": "ICD coding\n\n* ICD-10: [K13.21](https://www.icd10data.com/ICD10CM/Codes/K00-K95/K00-K14/K13-/K13.21) - Leukoplakia of oral mucosa, including tongue"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-5",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#epidemiology255311",
    "clean_content": "Epidemiology\n\n* Worldwide prevalence approximately 0.5% ([Oral Oncol 2003;39:770](13679200), [Oral Oncol 2009;45:317](18674954))* Characteristically a disease of older males (M:F = 3:1)"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-6",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#sites255312",
    "clean_content": "Sites\n\n* May present on any mucosal surface* Associated with highest incidences of malignant transformation when occurring on ventrolateral tongue or floor of mouth ([Oral Oncol 2009;45:317](18674954))"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-7",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#pathophysiology255313",
    "clean_content": "Pathophysiology\n\n* Leukoplakia exhibiting keratinizing dysplasia characterized by genomic alterations including *TP53* mutations and loss of heterozygosity at 3p and 9p ([Cancer Prev Res (Phila) 2012;5:1081](22911111))* Leukoplakia exhibiting hyperkeratosis alone characterized by genomic alterations including *KMT2C, TP53* and *TIAM1* mutations ([Oral Dis 2019;25:1707](31295753))* Genetic progression model of head and neck cancer not well worked out, particularly with regards to early precursor lesions ([Clin Cancer Res 2000;6:347](10690509))"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-8",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#etiology255314",
    "clean_content": "Etiology\n\n* Associated with smoking / smokeless tobacco, alcohol and areca nut (betel quid) use* HPV associated with only a very small percentage of cases ([Mod Pathol 2017;30:1646](28799537))"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-9",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#clinicalfeatures255315",
    "clean_content": "Clinical features\n\n* Hyperkeratosis on mucosal sites not amenable to frictional / factitial trauma, particularly when sharply demarcated, considered clinically concerning ([J Oral Maxillofac Surg 2017;75:723](27865803))* Biopsy proven leukoplakia may clinically appear homogenous or nonhomogenous ([Oral Oncol 2009;45:317](18674954))\n    + Homogenous leukoplakia: uniformly thin or thick hyperkeratosis, frequently sharply demarcated+ Nonhomogenous leukoplakia: irregular texture with fissuring, nodular / verrucous components or erythematous components (erythroleukoplakia)* Proliferative (verrucous) leukoplakia: uncommon and significantly more aggressive (60 - 100% malignant transformation rate) disease characterized by multifocal oral mucosal involvement and a predilection for middle aged / elderly females with no / minimal history of tobacco or alcohol exposure ([Oral Dis 2018;24:749](29337414))\n      + Best considered a separate disease on the basis of differing demographic / clinical presentation, biologic behavior and patient management considerations"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-10",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#diagnosis255316",
    "clean_content": "Diagnosis\n\n* Biopsy required for diagnosis and risk stratification* Leukoplakia with dysplasia readily diagnosed on basis of conventional histopathologic features of epithelial dysplasia ([Head Neck Pathol 2019;13:423](30887394))* Leukoplakia without dysplasia requires clinicopathologic correlation and exclusion of frictional / factitial features as identified clinically or histopathologically"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-11",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#prognosticfactors255317",
    "clean_content": "Prognostic factors\n\n* Annual malignant transformation rate 3% ([Oral Oncol 1998;34:270](9813722))* Presence of epithelial dysplasia most significant risk factor for malignant transformation ([Oral Oncol 2009;45:317](18674954), [Mod Pathol 2017;30:S112](28060368))\n    + Severe epithelial dysplasia: 28.4% risk+ Moderate epithelial dysplasia: 22.5% risk+ Mild epithelial dysplasia: 5.7% risk+ Hyperkeratosis: 4.9% risk* Reported overall malignant transformation rates of 0.36 - 34% difficult to interpret due to historical inclusion of frictional / reactive keratoses in leukoplakia cohorts and variability in followup duration ([J Oral Pathol Med 2016;45:155](26189354))* Length of duration, increasing size and nonhomogenous appearance associated with increased risk of malignant transformation"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-12",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#casereports255318",
    "clean_content": "Case reports\n\n* 21 year old man with amalgam associated leukoplakia ([J Oral Sci 2016;58:445](27665986))* 59 and 66 year old men with tongue leukoplakia and squamous cell carcinoma ([Mol Med Rep 2017;16:6780](28901451))* 75 year old man with tongue lesion ([Cleve Clin J Med 2020;87:133](32127435))"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-13",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#treatment255319",
    "clean_content": "Treatment\n\n* Surgical excision results in 3 times reduction in risk of malignant transformation ([Head Neck 2009;31:1600](19455705))* Leukoplakia with high grade (moderate / severe) dysplasia should be excised whenever possible* Close clinical observation may be appropriate for extensive leukoplakia or patients with comorbidities but otherwise appears to have a limited role when conservative surgical management is possible ([J Oral Maxillofac Surg 2017;75:723](27865803))"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-14",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Clinical images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#clinicalimages255320",
    "clean_content": "Clinical images\n\nContributed by Ivan J. Stojanov, D.M.D., M.M.Sc.  \n\n[![Left posterior maxillary leukoplakia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov01.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov01.jpg)\n\nLeft posterior maxillary leukoplakia\n\n[![Right posterior maxillary leukoplakia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov02.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov02.jpg)\n\nRight posterior maxillary leukoplakia\n\n[![Left ventral tongue leukoplakia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov03.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov03.jpg)\n\nLeft ventral tongue leukoplakia\n\n[![Extensive leukoplakia of tongue](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov04.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov04.jpg)\n\nExtensive leukoplakia of tongue"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-15",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#microscopichistologicdescription255321",
    "clean_content": "Microscopic (histologic) description\n\n* Leukoplakia with dysplasia exhibits characteristic architectural and cytological features of [keratinizing dysplasia](https://www.pathologyoutlines.com/topic/oralcavitydysplasia.html)\n  + Features include hyperkeratosis / parakeratosis, epithelial atrophy or hyperplasia with bulbous rete ridges, basal cell hyperplasia with nuclear hyperchromasia or increased nuclear cytoplasmic ratio, variable suprabasal or atypical mitoses, dyskeratosis or glassy cytoplasm, dyscohesion+ Approximately 33% of dysplasias are characterized by an inflammatory infiltrate and should not be misdiagnosed as [lichen planus](https://www.pathologyoutlines.com/topic/oralcavitylichenplanus.html) ([Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:511](24560560))* Leukoplakia without dysplasia exhibits hyperkeratosis with no histologic features of a frictional / reactive process but is otherwise less well characterized\n    + Histologic features include ([Head Neck Pathol 2019;13:423](30887394)):\n      - Compact hyperkeratosis with hypergranulosis- Subtle verrucoid architecture- Epithelial atrophy or hyperplasia+ If the periphery of the leukoplakia is sampled, hyperkeratosis will appear sharply demarcated* Some leukoplakias without dysplasia may exhibit prominent verrucous architecture and be reported as [verrucous hyperplasia](https://www.pathologyoutlines.com/topic/oralcavityverrucoushyperplasia.html)"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-16",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#microscopichistologicimages255322",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Ivan J. Stojanov, D.M.D., M.M.Sc.  \n\n[![Undulating / verrucoid surface architecture](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov05.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov05.jpg)\n\nUndulating / verrucoid surface architecture\n\n[![Absence of epithelial atypia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov06.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov06.jpg)\n\nAbsence of epithelial atypia\n\n[![Sharply demarcated hyperkeratosis](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov07.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov07.jpg)\n\nSharply demarcated hyperkeratosis\n\n[![Verrucous hyperplasia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov08.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov08.jpg)\n\nVerrucous hyperplasia\n\n[![Leukoplakia periphery](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov09.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov09.jpg)\n\nLeukoplakia periphery\n\n  \n\n[![Moderate dysplasia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov10.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov10.jpg)\n\nModerate dysplasia\n\n[![Leukoplakia with no dysplasia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov11.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov11.jpg)\n\nLeukoplakia with no dysplasia\n\n[![Parakeratosis and epithelial hyperplasia](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov12.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov12.jpg)\n\nParakeratosis and epithelial hyperplasia\n\n[![Hyperkeratosis and epithelial atrophy](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov13.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov13.jpg)\n\nHyperkeratosis and epithelial atrophy\n\n[![Minimal cytologic dysplastic features](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov14.jpg)](https://www.pathologyoutlines.com/imgau/oralcavityleukoplakiastojanov14.jpg)\n\nMinimal cytologic dysplastic features"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-17",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#cytologydescription255323",
    "clean_content": "Cytology description\n\n* Currently limited role for cytology:\n  + Difficulty sampling adequate tissue in unanaesthetized patients+ Epithelial atypia, if present, difficult to classify as reactive or dysplastic in absence of architectural features+ Patterns of keratinization cannot be assessed+ Oral cavity sites readily amenable to incisional biopsy"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-18",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#molecularcytogeneticsdescription255324",
    "clean_content": "Molecular / cytogenetics description\n\n* See [Pathophysiology](#oralcavityleukoplakiapatho)"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-19",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Molecular / cytogenetics images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#molecularcytogeneticsimages255325",
    "clean_content": "Molecular / cytogenetics images\n\nImages hosted on other servers:  \n\n[![CGH leukoplakia versus SCC](https://www.pathologyoutlines.com/thumb/oralcavityleukoplakiapmc01.jpg)](https://pubmed.ncbi.nlm.nih.gov/28901451/#&gid=article-figures&pid=figure-2-uid-1)\n\nCGH leukoplakia versus SCC\n\n[![Genes implicated in malignant transformation](https://www.pathologyoutlines.com/thumb/oralcavityleukoplakiapmc02.jpg)](https://pubmed.ncbi.nlm.nih.gov/28901451/#&gid=article-figures&pid=figure-3-uid-2)\n\nGenes implicated in malignant transformation"
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-20",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#samplepathologyreport255326",
    "clean_content": "Sample pathology report\n\n* Mandible, gingiva, incisional biopsy:\n  + Hyperkeratosis, epithelial atrophy and mild chronic inflammation, not reactive (see comment)+ Comment: The hyperkeratosis exhibits no features of a frictional / reactive process and resembles the surface keratinization commonly seen in epithelial dysplasias. Cytologic atypia is minimal / absent in this specimen but leukoplakia without dysplasia (hyperkeratosis that is not reactive) has malignant transformation rates of approximately 5%, similar to that of leukoplakia with mild dysplasia. The findings are consistent with the clinically observed leukoplakia, which in approximately 60% of cases presents without dysplasia. If the clinical context is appropriate, proliferative (verrucous) leukoplakia may also be considered."
  },
  {
    "id": "leukoplakia_36115_1750166912.txt-21",
    "source_document": "leukoplakia_36115_1750166912.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityleukoplakia.html#differentialdiagnosis255327",
    "clean_content": "Differential diagnosis\n\n* **Benign alveolar ridge keratosis**:\n  + Histologic features similar to lichen simplex chronicus+ Epithelial hyperplasia with verrucous / undulating surface and wedge shaped hypergranulosis+ Compact hyperkeratosis that tapers towards the edges and is not sharply demarcated+ Elongated rete ridges, occasionally confluent at tips+ No epithelial atypia+ Fibrosis and sparse chronic inflammation* **Chronic frictional / factitial keratosis**:\n    + Shaggy / macerated parakeratosis with superficial bacterial colonization+ Epithelial hyperplasia with keratinocyte edema but no epithelial atypia+ Variable fibrosis, acute and chronic inflammation and leukocyte exocytosis* [Lichen planus / lichenoid mucositis](https://www.pathologyoutlines.com/topic/oralcavitylichenplanus.html):\n      + Squamatization / degeneration of the basal cell layer with Civatte bodies (dyskeratotic keratinocytes)+ Band-like lymphoplasmahistiocytic infiltrate in the superficial lamina propria with leukocyte exocytosis and spongiosis* [Proliferative (verrucous) leukoplakia](https://www.pathologyoutlines.com/topic/oralcavityverrucoushyperplasia.html):\n        + Characterized clinically by multifocal leukoplakia\n          - Gingival involvement common+ Predilection for middle aged / elderly females and with no / minimal tobacco or alcohol exposure\n            - Reason for this association is unclear+ Indistinguishable histologically from leukoplakia+ Verrucous epithelial architecture common but not necessarily present"
  }
]